Juvenal Tobin W sold $232K of CSTL
Juvenal Tobin W (Chief Commercial Officer) sold 6,577 shares of CASTLE BIOSCIENCES INC (CSTL) at an average of $35.29 ($34.20–$35.50, $0.23M total) across 2 trades over 2026-09-29 to 2026-09-30 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest in size relative to the company's market cap, likely generating limited market reaction.
Market read
A small insider sell from a senior officer may cause slight short‑term pressure but is unlikely to move the stock materially.
What to watch
The 10b5-1 plan pre‑arranges sales, reducing the informational value of the transaction.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Chief Commercial Officer Juvenal Tobin W sold 6,577 shares for $232K via a 10b5-1 plan, reducing his stake to 52,007 shares.
likely slight pressure as the market prices in the insider sell
The sale amount is modest ($232K) but comes from a senior officer, which can prompt short‑term selling pressure.
Market effects
Minimal; biotech sector unlikely to be affected by a single insider sale.
None
None
Counterpoint
The sale could be routine portfolio rebalancing and not indicative of company fundamentals.
Key entities
- CompanyCastle Biosciences Inc.
Biotech firm listed on Nasdaq under ticker CSTL.
- ExecutiveJuvenal Tobin W
Chief Commercial Officer of Castle Biosciences.
